We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Anti-Treponema Immunohistochemistry Cross-Reactivity Reported with Non-Treponema Spirochetes

By LabMedica International staff writers
Posted on 12 Oct 2016
Syphilis has different histopathologic presentations, and it can mimic a significant number of entities while human intestinal spirochetosis is characterized by the presence of a layer of spirochetes adherent to the apical epithelial surface of the colorectal mucosa.

The spirochete species most often associated with this finding in humans are Brachyspira pilosicoli and Brachyspira aalborgi. More...
B.pilosicoli has been identified in other animals, such as pigs, rodents, and chickens, suggesting that the acquisition can be zoonotic. Higher prevalence rates are reported in developing countries, homosexual men, and human immunodeficient virus (HIV)-positive patients, who are also at increased risk for syphilis.

Medical scientists at the Cleveland Clinic (Cleveland, OH, USA) investigated the histopathologic findings of intestinal spirochetosis, which are different from those of syphilis. They used biopsies from eight patients with intestinal spirochetosis to evaluate the potential of cross-reactivity of a commercially available polyclonal antibody directed against Treponema pallidum, the causative agent of syphilis.

Hematoxylin-eosin stains and Warthin-Starry stains were available in all cases. The slides were reviewed and the diagnoses confirmed. In all biopsies, the hematoxylin-eosin–stained sections revealed a thickened and shaggy basophilic band on the apical cell membrane of the colorectal epithelium; Warthin-Starry stain demonstrated numerous spirochetes. Immunohistochemistry for T. pallidum (Biocare Medical, Concord, CA, USA) was performed on 2-μm sections of paraffin-embedded tissues, and the tissues were incubated 16 minutes at 37 °C. The protein-antibody complexes were located with the iView DAB Detection kit (Ventana Medical Systems, Oro Valley, AZ, USA). All biopsies showed strong positivity for the polyclonal antibody for T. pallidum.

The authors concluded that the potential for cross-reactivity of commercially available antibodies for T. pallidum with other spirochete species poses a potential diagnostic pitfall when biopsies are taken from locations wherein spirochetes may be encountered. The anti–T pallidum immunohistochemical stain remains a significant advance in the detection of T. pallidum spirochetes in the biopsies of patients with syphilis. It is important for the pathologist to be aware of this cross-reactivity with non-Treponema spirochetes. The histopathologic diagnosis of syphilis should not rest entirely on a positively staining spirochete. Rather, the diagnosis should be made based on the presence of the spirochetes with the appropriate histopathologic findings. The study was published in the October 2016 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:
Cleveland Clinic
Biocare Medical
Ventana Medical Systems


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
New
Shaking Incubator
Corning LSE 71L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Switching to an experimental drug after liquid biopsy detection of breast cancer recurrence can improve outcomes (Photo courtesy of Shutterstock)

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

Standard treatment for patients with advanced estrogen receptor (ER)-positive, HER2-negative breast cancer, a subtype driven by estrogen receptors that fuel tumor growth, often involves aromatase inhibitors,... Read more

Pathology

view channel
Image: A new at-home self-collection device aims to reduce the screening gap for cervical cancer (Photo courtesy of CU School of Medicine)

New At-Home Cervical Cancer Screening Device to Increase Accessibility for Patients

Cervical cancer is typically linked to certain types of human papillomavirus (HPV), which is passed through sexual contact. While many people are infected with HPV, only a small percentage will develop... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.